BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Brian A. Nadeau, Hari Conjeevaram. The gut microbiome and nonalcoholic fatty liver diseaseClinical Liver Disease 2017; 10(5): 116 doi: 10.1002/cld.671
2
Kareem Hassan, Varun Bhalla, Mohammed Ezz El Regal, H Hesham A-Kader. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemicWorld Journal of Gastroenterology 2014; 20(34): 12082-12101 doi: 10.3748/wjg.v20.i34.12082
3
Neerja Hajela, B. S. Ramakrishna, G. Balakrish Nair, Philip Abraham, Sarath Gopalan, Nirmal K. Ganguly. Gut microbiome, gut function, and probiotics: Implications for healthIndian Journal of Gastroenterology 2015; 34(2): 93 doi: 10.1007/s12664-015-0547-6
4
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiotaMolecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
5
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD008716.pub3
6
Yong Kyun Cho. Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?Clinical and Molecular Hepatology 2018; 24(3): 299 doi: 10.3350/cmh.2018.1006
7
Muhammad Y. Khan, Albana B. Mihali, Muhammad S. Rawala, Aysha Aslam, Waqas J. Siddiqui. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2019; 31(6): 703 doi: 10.1097/MEG.0000000000001371
8
Sanjoy Roychowdhury, Praveen Selvakumar, Gail Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver DiseaseMedical Sciences 2018; 6(2): 47 doi: 10.3390/medsci6020047
9
R. Barazzoni, N.E.P. Deutz, G. Biolo, S. Bischoff, Y. Boirie, T. Cederholm, C. Cuerda, N. Delzenne, M. Leon Sanz, O. Ljungqvist, M. Muscaritoli, C. Pichard, J.C. Preiser, P. Sbraccia, P. Singer, L. Tappy, B. Thorens, A. Van Gossum, R. Vettor, P.C. Calder. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert groupClinical Nutrition 2017; 36(2): 355 doi: 10.1016/j.clnu.2016.09.010
10
Wenke Feng, Craig McClain. Molecules, Systems and Signaling in Liver Injury2017; : 251 doi: 10.1007/978-3-319-58106-4_11
11
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsWorld Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
12
Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq. Possible hepatocellular toxicity of EGCG under the influence of an inflammagenJournal of Applied Biomedicine 2014; 12(4): 291 doi: 10.1016/j.jab.2014.03.001
13
C. Punzalan, A. Qamar. The Microbiota in Gastrointestinal Pathophysiology2017; : 373 doi: 10.1016/B978-0-12-804024-9.00040-9
14
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescentsExpert Review of Clinical Pharmacology 2017; 10(11): 1225 doi: 10.1080/17512433.2017.1365599
15
Cat. Buffet, Cam. Buffet. Les hépatopathies stéatosiques non alcooliques et le microbiote intestinalMédecine des Maladies Métaboliques 2015; 9(3): 301 doi: 10.1016/S1957-2557(15)30078-X
16
T. Vaikunthanathan, N. Safinia, G. Lombardi, R.I. Lechler. Microbiota, immunity and the liverImmunology Letters 2016; 171: 36 doi: 10.1016/j.imlet.2016.01.008
17
Pramodini Kale-Pradhan, Sheila Wilhelm. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition2017;  doi: 10.21019/9781582122656.ch20
18
Ali Abdul-Hai, Ali Abdallah, Stephen DH Malnick. Influence of gut bacteria on development and progression of non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(12): 1679-1684 doi: 10.4254/wjh.v7.i12.1679
19
Vishal Singh, Beng San Yeoh, James M. Ntambi, Matam Vijay-Kumar. Hepatic De Novo Lipogenesis and Regulation of Metabolism2016; : 189 doi: 10.1007/978-3-319-25065-6_9
20
Jun-Ling Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspectiveWorld Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: 10.3748/wjg.v20.i47.17737
21
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari. The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver DiseaseNutrients 2014; 6(12): 5583 doi: 10.3390/nu6125583
22
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7109270
23
Giulia Paolella, Claudia Mandato, Luca Pierri, Marco Poeta, Martina Di Stasi, Pietro Vajro. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(42): 15518-15531 doi: 10.3748/wjg.v20.i42.15518
24
Anne Sophie Schneck, Rodolphe Anty, Albert Tran, Audrey Hastier, Imed Ben Amor, Jean Gugenheim, Antonio Iannelli, Thierry Piche. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric SurgeryObesity Surgery 2016; 26(7): 1525 doi: 10.1007/s11695-015-1907-0
25
Hannele Yki-Järvinen. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease2016; : 189 doi: 10.1002/9781118924938.ch21
26
Vanessa Stadlbauer-Köllner. Probiotika bei LebererkrankungenWiener klinisches Magazin 2018; 21(6): 240 doi: 10.1007/s00740-018-0250-1
27
Laura Baselga-Escudero, Vanessa Souza-Mello, Aïda Pascual-Serrano, Tamiris Rachid, Adriana Voci, Ilaria Demori, Elena Grasselli. Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver diseaseTrends in Food Science & Technology 2017; 61: 141 doi: 10.1016/j.tifs.2016.11.019
28
Nazarii Kobyliak, Caterina Conte, Giovanni Cammarota, Andreana P. Haley, Igor Styriak, Ludovit Gaspar, Jozef Fusek, Luis Rodrigo, Peter Kruzliak. Probiotics in prevention and treatment of obesity: a critical viewNutrition & Metabolism 2016; 13(1) doi: 10.1186/s12986-016-0067-0
29
Diptadip Dattaroy, Ratanesh Kumar Seth, Suvarthi Das, Firas Alhasson, Varun Chandrashekaran, Gregory Michelotti, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(7): G510 doi: 10.1152/ajpgi.00259.2015
30
Abdel-Naser Elzouki. Probiotics and Liver DiseaseJournal of Clinical Gastroenterology 2016; 50: S188 doi: 10.1097/MCG.0000000000000712
31
Alireza Milajerdi, Seyyed Mohammad Mousavi, Alireza Sadeghi, Asma Salari-Moghaddam, Mohammad Parohan, Bagher Larijani, Ahmad Esmaillzadeh. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trialsEuropean Journal of Nutrition 2019;  doi: 10.1007/s00394-019-01931-8
32
Silvia M. Ferolla, Cláudia A. Couto, Maria de Lourdes A. Ferrari, Luciana Costa Faria, Murilo Pereira, Teresa C.A. Ferrari. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications2019; : 265 doi: 10.1016/B978-0-12-815249-2.00027-0
33
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trialsInternational Journal of Food Sciences and Nutrition 2016; 67(5): 571 doi: 10.1080/09637486.2016.1181156
34
S. Fine, C.R. Kelly. The Microbiota in Gastrointestinal Pathophysiology2017; : 315 doi: 10.1016/B978-0-12-804024-9.00034-3
35
J. P. Ong, Z. M. Younossi. Editorial: probiotics in NASH - more studies are neededAlimentary Pharmacology & Therapeutics 2014; 40(2): 211 doi: 10.1111/apt.12812
36
Saumya Jayakumar, Rohit Loomba. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implicationsAlimentary Pharmacology & Therapeutics 2019; 50(2): 144 doi: 10.1111/apt.15314
37
Frank Tacke, Ralf Weiskirchen. An update on the recent advances in antifibrotic therapyExpert Review of Gastroenterology & Hepatology 2018; 12(11): 1143 doi: 10.1080/17474124.2018.1530110
38
Liang Liu, Ping Li, Yiqi Liu, Yilian Zhang. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-AnalysisDigestive Diseases and Sciences 2019;  doi: 10.1007/s10620-019-05699-z
39
Suzanne E. Mahady, Jacob George. Exercise and diet in the management of nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1172 doi: 10.1016/j.metabol.2015.10.032
40
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterologíaRevista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
41
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
42
Floriana Elvira Ionică, Simona Negreș, Ludovic Bejenaru, Cornelia Bejenaru, Cornel Chiriță. Pharmacological Approaches for Nonalcoholic Fatty Liver DiseaseRomanian Journal of Diabetes Nutrition and Metabolic Diseases 2016; 23(3) doi: 10.1515/rjdnmd-2016-0037
43
İhsan Boyacı, Süleyman Yıldırım. Metabolik Sendrom Tedavisinde Bağırsak Mikrobiyotasının Probiyotikler ve Özelinde Saccharomyces Boulardii ile ModülasyonuAnadolu Kliniği Tıp Bilimleri Dergisi 2017;  doi: 10.21673/anadoluklin.260702
44
Brandon Perumpail, Andrew Li, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLDDiseases 2019; 7(1): 27 doi: 10.3390/diseases7010027
45
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver CancerAdvances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
46
J. Pang, W. Xu, X. Zhang, G. L.-H. Wong, A. W.-H. Chan, H.-Y. Chan, C.-H. Tse, S. S.-T. Shu, P. C.-L. Choi, H. L.-Y. Chan, J. Yu, V. W.-S. Wong. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2017; 46(2): 175 doi: 10.1111/apt.14119
47
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterologyRevista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
48
Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S. Bajaj, Rajiv Jalan. Targeting the gut-liver axis in liver diseaseJournal of Hepatology 2017; 67(5): 1084 doi: 10.1016/j.jhep.2017.05.007
49
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Probiotics for dietary management of non-alcoholic fatty liver diseaseEnvironmental Chemistry Letters 2019;  doi: 10.1007/s10311-019-00896-8
50
Atefe Asgharian, Vida Mohammadi, Zahra Gholi, Ahmad Esmaillzade, Awat Feizi, Gholamreza Askari. The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial StudyIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.42902
51
Ramesh C. Chandan, Akanksha Gandhi, Nagendra P. Shah. Yogurt in Health and Disease Prevention2017; : 3 doi: 10.1016/B978-0-12-805134-4.00001-8
52
Grace Hatton, Tommaso Alterio, Valerio Nobili, Jake P. Mann. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?Expert Review of Gastroenterology & Hepatology 2018; 12(10): 961 doi: 10.1080/17474124.2018.1512853
53
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocolBMJ Open 2017; 7(7): e016914 doi: 10.1136/bmjopen-2017-016914
54
Jichun Zhao, Fengwei Tian, Nan Zhao, Qixiao Zhai, Hao Zhang, Wei Chen. Effects of probiotics on d -galactose-induced oxidative stress in plasma: A meta-analysis of animal modelsJournal of Functional Foods 2017; 39: 44 doi: 10.1016/j.jff.2017.09.055
55
Beng San Yeoh, Matam Vijay-Kumar. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases2018; : 129 doi: 10.1007/978-1-4939-7534-1_7
56
Jag Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela Starke-Reed, Van S. Hubbard. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision MedicineClinical Pharmacology in Drug Development 2017; 6(2): 176 doi: 10.1002/cpdd.310
57
Michelle L. Dossett, Ezra M. Cohen, Jonah Cohen. Integrative Medicine for Gastrointestinal DiseasePrimary Care: Clinics in Office Practice 2017; 44(2): 265 doi: 10.1016/j.pop.2017.02.002
58
Mariangela Rondanelli, Milena Anna Faliva, Simone Perna, Attilio Giacosa, Gabriella Peroni, Anna Maria Castellazzi. Using probiotics in clinical practice: Where are we now? A review of existing meta-analysesGut Microbes 2017; 8(6): 521 doi: 10.1080/19490976.2017.1345414
59
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
60
Robert S. Lo, Andrew S. Austin, Jan G. Freeman. Is There a Role for Probiotics in Liver Disease?The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/874768
61
Masami Minemura, Yukihiro Shimizu. Gut microbiota and liver diseasesWorld Journal of Gastroenterology 2015; 21(6): 1691-1702 doi: 10.3748/wjg.v21.i6.1691
62
Abdolmajid Ghasemian, Majid Eslami, Morvarid Shafiei, Sohrab Najafipour, Ali Rajabi. Probiotics and their increasing importance in human health and infection controlReviews in Medical Microbiology 2018; 29(4): 153 doi: 10.1097/MRM.0000000000000147
63
Claudia Della Corte, Pietro Vajro, Piotr Socha, Valerio Nobili. Pediatric non-alcoholic fatty liver disease: Recent advancesClinics and Research in Hepatology and Gastroenterology 2014; 38(4): 419 doi: 10.1016/j.clinre.2014.02.008
64
Amanda Chaney. Treating the patient with nonalcoholic fatty liver diseaseThe Nurse Practitioner 2015; 40(11): 36 doi: 10.1097/01.NPR.0000472248.28703.18
65
Gina P. Rodriguez-Castaño, Alejandro Caro-Quintero, Alejandro Reyes, Fernando Lizcano. Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western LifestyleFrontiers in Genetics 2017; 7 doi: 10.3389/fgene.2016.00224
66
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiotaMetabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
67
Norberto C. Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka Barbero-Becerra, Eva Juárez-Hernández, Juan L. Romero-Flores, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe. Current evidence on the use of probiotics in liver diseasesJournal of Functional Foods 2015; 17: 137 doi: 10.1016/j.jff.2015.05.009
68
Bobae Kim, Jeonghyeon Kwon, Min-Seok Kim, Haryung Park, Yosep Ji, Wilhelm Holzapfel, Chang-Kee Hyun, Marcia B. Aguila. Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in micePLOS ONE 2018; 13(12): e0210120 doi: 10.1371/journal.pone.0210120
69
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical TrialIranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
70
Céline Druart, Maud Alligier, Nuria Salazar, Audrey M. Neyrinck, Nathalie M. Delzenne. Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic PropertiesAdvances in Nutrition 2014; 5(5): 624S doi: 10.3945/an.114.005835
71
Uday C. Ghoshal, Chalamalasetty Sreenivasa Baba, Ujjala Ghoshal, George Alexander, Asha Misra, Vivek A Saraswat, Gourdas Choudhuri. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate cultureIndian Journal of Gastroenterology 2017; 36(5): 390 doi: 10.1007/s12664-017-0797-6
72
E. B. Mitchel, J. E. Lavine. Review article: the management of paediatric nonalcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2014; 40(10): 1155 doi: 10.1111/apt.12972
73
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
74
Pietro Vajro, Marco Poeta, Luca Pierri, Cristina Pizza, Roberta D’Aniello, Maria Sangermano, Grazia Massa, Giulia Paolella. Nutrition in the Prevention and Treatment of Abdominal Obesity2014; : 363 doi: 10.1016/B978-0-12-407869-7.00033-7
75
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal, Ailsa Hart. The gut microbiota and host health: a new clinical frontierGut 2016; 65(2): 330 doi: 10.1136/gutjnl-2015-309990
76
Gregor Lorbek, Žiga Urlep, Damjana Rozman. Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver diseasePharmacogenomics 2016; 17(11): 1273 doi: 10.2217/pgs-2016-0047
77
Nadia Juliana Beraldo Goulart Borge Haubert, Julio Sergio Marchini, Selma Freire Carvalho Cunha, Vivian Marques Miguel Suen, Gilberto Joao Padovan, Alceu Afonso Jordao Junior, Claudia Maria Meirelles Marchini Alves, Julio Flavio Meirelles Marchini, Helio Vannucchi. Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress MarkersNutrition and Metabolic Insights 2015; 8: NMI.S24385 doi: 10.4137/NMI.S24385
78
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureWorld Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
79
Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, R Scott Rector. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysisNutrition Reviews 2018; 76(11): 822 doi: 10.1093/nutrit/nuy031
80
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver diseaseNutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
81
Silvia M. Ferolla. Obesity2016; : 159 doi: 10.1007/978-3-319-19821-7_13
82
Sang Hak Han, Ki Tae Suk, Dong Joon Kim, Moon Young Kim, Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi, Young Lim Ham, Dong Hoon Shin, Eun Ji Kim. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitisEuropean Journal of Gastroenterology & Hepatology 2015; 27(11): 1300 doi: 10.1097/MEG.0000000000000458
83
Mehri Jamilian, Elaheh Amirani, Zatollah Asemi. The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trialClinical Nutrition 2018;  doi: 10.1016/j.clnu.2018.10.028
84
Lucio Capurso. Thirty Years of Lactobacillus rhamnosus GGJournal of Clinical Gastroenterology 2019; 53: S1 doi: 10.1097/MCG.0000000000001170
85
Ahad Eshraghian. Current and emerging pharmacological therapy for non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(42): 7495-7504 doi: 10.3748/wjg.v23.i42.7495
86
K. A. Aitbaev, I. T. Murkamilov, V. V. Fomin. Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulationTerapevticheskii arkhiv 2017; 89(8): 120 doi: 10.17116/terarkh2017898120-128
87
Haripriya Maddur, Brent A Neuschwander-Tetri. More evidence that probiotics may have a role in treating fatty liver diseaseThe American Journal of Clinical Nutrition 2014; 99(3): 425 doi: 10.3945/ajcn.113.082636
88
Suzanne R Sharpton, Bharat Maraj, Emily Harding-Theobald, Eric Vittinghoff, Norah A Terrault. Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regressionThe American Journal of Clinical Nutrition 2019; 110(1): 139 doi: 10.1093/ajcn/nqz042
89
Jennifer E. Lambert, Jill A. Parnell, Bertus Eksteen, Maitreyi Raman, Marc R. Bomhof, Kevin P. Rioux, Karen L. Madsen, Raylene A. Reimer. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocolBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0400-5
90
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2015; 16(10): 25168 doi: 10.3390/ijms161025168
91
Davide Festi, Ramona Schiumerini, Leonardo Henry Eusebi, Giovanni Marasco, Martina Taddia, Antonio Colecchia. Gut microbiota and metabolic syndromeWorld Journal of Gastroenterology 2014; 20(43): 16079-16094 doi: 10.3748/wjg.v20.i43.16079
92
IG Saleh, Z Ali, MA Hammad, FD Wilson, FM Hamada, MF Abd-Ellah, LA Walker, IA Khan, MK Ashfaq. Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in miceHuman & Experimental Toxicology 2015; 34(11): 1180 doi: 10.1177/0960327115572707
93
Myungsuk Kim, Young Gyun Park, Hee-Ju Lee, Sue Ji Lim, Hong Ryul Ahn, Sang Hoon Jung, Chu Won Nho. Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolismJournal of Functional Foods 2015; 18: 714 doi: 10.1016/j.jff.2015.09.002
94
M.-Y. Park, S.J. Kim, E.K. Ko, S.-H. Ahn, H. Seo, M.-K. Sung. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob miceJournal of Applied Microbiology 2016; 121(3): 800 doi: 10.1111/jam.13158
95
Yosep Ji, Young Mee Chung, Soyoung Park, Dahye Jeong, Bongjoon Kim, Wilhelm Heinrich Holzapfel. Dose-dependent and strain-dependent anti-obesity effects of Lactobacillus sakei in a diet induced obese murine modelPeerJ 2019; 7: e6651 doi: 10.7717/peerj.6651
96
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada. Impact of Nutritional Changes on Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(3): 677 doi: 10.3390/nu11030677
97
Juliana Paula Bruch-Bertani, Carolina Uribe-Cruz, Amanda Pasqualotto, Larisse Longo, Raquel Ayres, Carolina Bortolin Beskow, Afonso Luis Barth, Daiana Lima-Morales, Fábio Meurer, Gabriel Tayguara Silveira Guerreiro, Themis Reverbel da Silveira, Mário Reis Álvares-da-Silva, Valesca Dall’Alba. Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in ZebrafishJournal of the American College of Nutrition 2019; : 1 doi: 10.1080/07315724.2019.1627955
98
Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva, Galyna Mykhalchyshyn, Luigi Boccuto, Liudmyla Kononenko, Dmytro Kyriienko, Iuliia Komisarenko, Oleg Dynnyk. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical studyMinerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05845-7
99
Reenam S. Khan, Fernando Bril, Kenneth Cusi, Philip N. Newsome. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseHepatology 2019;  doi: 10.1002/hep.30429
100
Marco Toscano, Roberta De Grandi, Luca Pastorelli, Maurizio Vecchi, Lorenzo Drago. A consumer’s guide for probiotics: 10 golden rules for a correct useDigestive and Liver Disease 2017; 49(11): 1177 doi: 10.1016/j.dld.2017.07.011
101
Bobae Kim, Kun-Young Park, Yosep Ji, Soyoung Park, Wilhelm Holzapfel, Chang-Kee Hyun. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese miceBiochemical and Biophysical Research Communications 2016; 473(2): 530 doi: 10.1016/j.bbrc.2016.03.107
102
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatologyClinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
103
Jay Luther, John J. Garber, Hamed Khalili, Maneesh Dave, Shyam Sundhar Bale, Rohit Jindal, Daniel L. Motola, Sanjana Luther, Stefan Bohr, Soung Won Jeoung, Vikram Deshpande, Gurminder Singh, Jerrold R. Turner, Martin L. Yarmush, Raymond T. Chung, Suraj J. Patel. Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal PermeabilityCellular and Molecular Gastroenterology and Hepatology 2015; 1(2): 222 doi: 10.1016/j.jcmgh.2015.01.001
104
Nearmeen M. Rashad, Amal S. El-Shal, Abdelaziz I. Amin, Manar H. Soliman. Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndromeJournal of Functional Foods 2017; 36: 317 doi: 10.1016/j.jff.2017.06.029
105
Thomas Tu, Magdalena Budzinska, Annette Maczurek, Robert Cheng, Anna Di Bartolomeo, Fiona Warner, Geoffrey McCaughan, Susan McLennan, Nicholas Shackel. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and DevelopmentInternational Journal of Molecular Sciences 2014; 15(6): 9422 doi: 10.3390/ijms15069422
106
Amir Hadi, Hamed Mohammadi, Maryam Miraghajani, Ehsan Ghaedi. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLDCritical Reviews in Food Science and Nutrition 2019; 59(15): 2494 doi: 10.1080/10408398.2018.1458021
107
Xiaolin Gao, Yu Zhu, Yang Wen, Guanjian Liu, Chaomin Wan. Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trialsHepatology Research 2016; 46(12): 1226 doi: 10.1111/hepr.12671
108
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
109
Hessah Mohammed Al-muzafar, Kamal Adel Amin. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkersBMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1540-z
110
Luis Vitetta, Sean Hall, Samantha Coulson. Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage InfluencesMicroorganisms 2015; 3(4): 913 doi: 10.3390/microorganisms3040913
111
Jin-Chul Kim, Joo-Yeong Jeon, Woong-suk Yang, Cheorl-Ho Kim, Dae-Woon Eom. Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver DiseaseCurrent Pharmaceutical Biotechnology 2019; 20(3): 222 doi: 10.2174/1389201020666190311143554
112
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver diseaseAtherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
113
Jessica Tsuei, Thinh Chau, David Mills, Yu-Jui Yvonne Wan. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancerExperimental Biology and Medicine 2014; 239(11): 1489 doi: 10.1177/1535370214538743
114
S Sherf-Dagan, S Zelber-Sagi, G Zilberman-Schapira, M Webb, A Buch, A Keidar, A Raziel, N Sakran, D Goitein, N Goldenberg, J A Mahdi, M Pevsner-Fischer, N Zmora, M Dori-Bachash, E Segal, E Elinav, O Shibolet. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trialInternational Journal of Obesity 2018; 42(2): 147 doi: 10.1038/ijo.2017.210
115
Christopher Irwin, Saman Khalesi, Amanda J. Cox, Gary Grant, Andrew K. Davey, Andrew C. Bulmer, Ben Desbrow. Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot studyEuropean Journal of Nutrition 2018; 57(4): 1523 doi: 10.1007/s00394-017-1437-8
116
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal DiseaseClinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
117
Hyeyoon Eo, You-jin Jeon, Myoungsook Lee, Yunsook Lim. Brown Alga Ecklonia cava Polyphenol Extract Ameliorates Hepatic Lipogenesis, Oxidative Stress, and Inflammation by Activation of AMPK and SIRT1 in High-Fat Diet-Induced Obese MiceJournal of Agricultural and Food Chemistry 2015; 63(1): 349 doi: 10.1021/jf502830b
118
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. Donohue, Kusum K. Kharbanda, Marcus Cruz, Mihai Opris. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damageExperimental and Molecular Pathology 2017; 102(1): 162 doi: 10.1016/j.yexmp.2017.01.003
119
INFLUENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH ON THE COMPLICATIONS OF PORTAL HYPERTENSION IN ITS VARIOUS FORMS Bulletin of Problems Biology and Medicine  doi: 10.29254/2077-4214-2018-1-2-143-195-198
120
Silvia Marinho Ferolla, Geyza Nogueira de Almeida Armiliato, Cláudia Alves Couto, Teresa Cristina Abreu Ferrari. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(3): 559-565 doi: 10.4254/wjh.v7.i3.559
121
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetInternational Journal of Molecular Sciences 2016; 17(4): 481 doi: 10.3390/ijms17040481
122
Yanjun Cui, Sirui Qi, Wenming Zhang, Jiangdi Mao, Renlong Tang, Chong Wang, Jianxin Liu, Xin M Luo, Haifeng Wang. Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by LipopolysaccharideThe Journal of Nutrition 2019;  doi: 10.1093/jn/nxz088
123
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?Journal of Digestive Diseases 2019;  doi: 10.1111/1751-2980.12751
124
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver DiseaseMedicina 2019; 55(5): 166 doi: 10.3390/medicina55050166
125
Yasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Soichiro Saikawa, Shinya Sato, Kenichiro Seki, Hiroaki Takaya, Yasushi Okura, Kosuke Kaji, Naotaka Shimozato, Tsuyoshi Mashitani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitisHepatology Research 2019; 49(3): 284 doi: 10.1111/hepr.13281
126
Asma Kazemi, Sepideh Soltani, Sima Ghorabi, Abbas Keshtkar, Elnaz Daneshzad, Fatemeh Nasri, Seyed Mohammad Mazloomi. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trialsClinical Nutrition 2019;  doi: 10.1016/j.clnu.2019.04.004
127
Somayyeh Firouzi, Barakatun-Nisak Mohd-Yusof, Hazreen-Abd Majid, Amin Ismail, Nor-Azmi Kamaruddin. Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trialBMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0952-5
128
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trialsMedicina 2016; 52(1): 28 doi: 10.1016/j.medici.2015.11.008
129
Paraskevas Gkolfakis, George Dimitriadis, Konstantinos Triantafyllou. Gut microbiota and non-alcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2015; 14(6): 572 doi: 10.1016/S1499-3872(15)60026-1
130
Naga S. Betrapally, Patrick M. Gillevet, Jasmohan S. Bajaj. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?Gastroenterology 2016; 150(8): 1745 doi: 10.1053/j.gastro.2016.02.073
131
Irina A. Kirpich, Luis S. Marsano, Craig J. McClain. Gut–liver axis, nutrition, and non-alcoholic fatty liver diseaseClinical Biochemistry 2015; 48(13-14): 923 doi: 10.1016/j.clinbiochem.2015.06.023
132
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disordersInternational Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
133
Jerome Boursier, Anna Mae Diehl. Nonalcoholic Fatty Liver Disease and the Gut MicrobiomeClinics in Liver Disease 2016; 20(2): 263 doi: 10.1016/j.cld.2015.10.012
134
Barry A. Mizock. ProbioticsDisease-a-Month 2015; 61(7): 259 doi: 10.1016/j.disamonth.2015.03.011
135
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the LiteratureInternational Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
136
Carly E Kelley, Ann J Brown, Anna Mae Diehl, Tracy L Setji. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndromeWorld Journal of Gastroenterology 2014; 20(39): 14172-14184 doi: 10.3748/wjg.v20.i39.14172
137
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseJournal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4597246
138
Maurizio Koch. Gut Microbiota and the LiverJournal of Clinical Gastroenterology 2016; 50: S183 doi: 10.1097/MCG.0000000000000699
139
S. Gitto, G. Vitale, E. Villa, P. Andreone. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and FutureGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/732870